Sign Up to like & get
recommendations!
1
Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.34200
Abstract: Key Points Question What is the comparative effectiveness and safety of vedolizumab vs tumor necrosis factor (TNF) antagonists for older patients with inflammatory bowel diseases (IBDs)? Findings In a comparative effectiveness study of 754 older…
read more here.
Keywords:
necrosis factor;
safety;
vedolizumab tumor;
tumor necrosis ... See more keywords